{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:47:32Z","timestamp":1792090052830,"version":"4.4.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"NIHR University College London Hospitals Biomedical Research Centre (London, United Kingdom)","award":["A8971 CRUK\/07\/030"],"award-info":[{"award-number":["A8971 CRUK\/07\/030"]}]},{"DOI":"10.13039\/100010377","name":"NICE","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010377","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvir.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jvir.2019.03.018","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T23:56:41Z","timestamp":1561593401000},"page":"1185-1192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Yttrium-90 Transarterial Radioembolization for Chemotherapy-Refractory Intrahepatic Cholangiocarcinoma: A\u00a0Prospective, Observational Study"],"prefix":"10.1016","volume":"30","author":[{"given":"Judith","family":"White","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Carolan-Rees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah E.","family":"Patrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teik Choon","family":"See","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon K.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek M.","family":"Manas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Crellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Slevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricky A.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2019.03.018_bib1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2217\/hep-2017-0014","article-title":"Locoregional therapies in cholangiocarcinoma","volume":"4","author":"Labib","year":"2017","journal-title":"Hepat Oncol"},{"key":"10.1016\/j.jvir.2019.03.018_bib2","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvir.2019.03.018_bib3","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","article-title":"Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma","volume":"60","author":"Bridgewater","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jvir.2019.03.018_bib4","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1093\/annonc\/mdu162","article-title":"Second-line chemotherapy in advanced biliary cancer: a systematic review","volume":"25","author":"Lamarca","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jvir.2019.03.018_bib5","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s00259-011-1812-2","article-title":"EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds","volume":"38","author":"Giammarile","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jvir.2019.03.018_bib6","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejso.2014.09.007","article-title":"Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis","volume":"41","author":"Al-Adra","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jvir.2019.03.018_bib7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/jso.23781","article-title":"Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma","volume":"111","author":"Boehm","year":"2015","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.jvir.2019.03.018_bib8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.clon.2014.09.009","article-title":"Selective internal radiotherapy of the liver: at the crossroads of interventional oncology research and national health service commissioning","volume":"26","author":"Sharma","year":"2014","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.jvir.2019.03.018_bib9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.clon.2018.09.002","article-title":"Analysis of a national programme for selective internal radiation therapy for colorectal cancer liver metastases","volume":"31","author":"White","year":"2019","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.jvir.2019.03.018_bib10","author":"NHS England"},{"key":"10.1016\/j.jvir.2019.03.018_bib11","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jvir.2019.03.018_bib12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1017\/S0266462307070651","article-title":"Coverage with evidence development: an examination of conceptual and policy issues","volume":"23","author":"Hutton","year":"2007","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.jvir.2019.03.018_bib13","first-page":"161","article-title":"Radioembolization for unresectable intrahepatic cholangiocarcinoma: review of safety, response evaluation criteria in solid tumors 1.1 imaging response and survival","volume":"32","author":"Swinburne","year":"2017","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.jvir.2019.03.018_bib14","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jvir.2018.04.001","article-title":"Intrahepatic cholangiocarcinoma treated with transarterial yttrium-90 glass microsphere radioembolization: results of a single institution retrospective study","volume":"29","author":"Gangi","year":"2018","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2019.03.018_bib15","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00259-018-4199-5","article-title":"Yttrium-90 glass microsphere radioembolization (RE) for biliary tract cancer: a large single-center experience","volume":"46","author":"Bourien","year":"2019","journal-title":"Eur J Nuc Med Mol Imaging"},{"key":"10.1016\/j.jvir.2019.03.018_bib16","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1200\/JCO.2010.28.5643","article-title":"Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy","volume":"28","author":"Hendlisz","year":"2010","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044319303653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044319303653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T06:02:44Z","timestamp":1760940164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044319303653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1051044319303653"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2019.03.018","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Yttrium-90 Transarterial Radioembolization for Chemotherapy-Refractory Intrahepatic Cholangiocarcinoma: A\u00a0Prospective, Observational Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvir.2019.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 SIR, 2019","name":"copyright","label":"Copyright"}]}}